NCT02521064View on ClinicalTrials.gov

Effects of Exclusive Enteral Nutrition on the Microbiome in Pediatric Inflammatory Bowel Disease

CompletedOBSERVATIONAL
Enrollment

31

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Inflammatory Bowel Diseases
Interventions
DIETARY_SUPPLEMENT

Exclusive Enteral Nutrition (EEN)

Patients will be treated with 8 weeks of Exclusive Enteral Nutrition (EEN). Patients will continue to receive usual medical care, and concurrent IBD treatments will be permitted.

DRUG

Prednisone

Patients will be treated with 8 weeks of prednisone (corticosteroid). Patients will continue to receive usual medical care, and concurrent IBD treatments will be permitted.

Trial Locations (1)

L8N3Z5

McMaster Children's Hospital, Hamilton

All Listed Sponsors
collaborator

Canadian Association of Gastroenterology

INDUSTRY

lead

McMaster Children's Hospital

OTHER

NCT02521064 - Effects of Exclusive Enteral Nutrition on the Microbiome in Pediatric Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter